European Society of Toxicology In Vitro > News > ATLA Launching 4 special issues on NAMs!
1 April 2021

ATLA Launching 4 special issues on NAMs!

The four special virtual issues are focusing on:

  • Biobanking – discuss the suitability of your MS with the VSC Editor Rita Seabra <rita@frame.org.uk>
  • In silico tools – discuss the suitability of your MS with the VSC Editor Judith Madden <J.C.Madden@ljmu.ac.uk>
  • Serum-free approaches – discuss the suitability of your MS with the VSC Editor Helena Kandarova <helena.kandarova@outlook.sk>
  • Educational resources – discuss thesuitability of your MS with the VSC Editor Esther Haugabrooks <EHaugabrooks@pcrm.org>

Articles will be made available online (subject to access rights) as soon as they are published.
• High visibility on the award-winning SAGE Journals platform, securing a wide international audience, including researchers, policymakers and educators.
• Prompt publishing and no submission or publication fees payable.

About the journal
ATLA is a peer-reviewed international journal that has been at the forefront of promoting and publishing on all aspects of the development, validation, implementation and use of animal alternatives, for almost 50 years. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo experiments that are still carried out (the Three Rs).

Related content

Registration to the ESTIV 2024 Congress in Prague, June 3-6 is open!

  • News

We are pleased to announce that the registration for the 22nd international congress of the European Society of Toxicology In Vitro (ESTIV2024) is open now! The congress will take place 3 – 6 June 2024 in Cubex Centre in Prague, Czech Republic.

ESTIV 2024 Congress bursary for the winner of the ASPIS Open Symposium Best Poster Award

  • News

ESTIV 2024 Congress bursary for the winner of the ASPIS Open Symposium Best Poster Award

IVTIP donation to support the ESTIV training courses

  • News

IVTIP has chosen to transfer its remaining funds to ESTIV, recognizing our shared commitment to excellence in toxicology education.

Gold Sponsor

Memorandum of Understanding